Evolus Inc.(EOLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EOLS Evolus Inc.

Market Closed 07-10 16:00:00 EDT

6.61

-0.24

-3.50%

盘后6.61

+0.000.00%

16:30 EDT

High6.87	Low6.40	Vol639.11K
Open6.85	D1 Closing6.85	Amplitude6.86%
Mkt Cap435.30M	Tradable Cap345.49M	Total Shares65.85M
T/O4.19M	T/O Rate1.22%	Tradable Shares52.27M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EOLS","market":"US","secType":"STK","nameCN":"Evolus Inc.","latestPrice":6.61,"timestamp":1783713600000,"preClose":6.85,"halted":0,"volume":639112,"hourTrading":{"tag":"盘后","latestPrice":6.61,"preClose":6.61,"latestTime":"16:30 EDT","volume":5785,"amount":38239.545,"timestamp":1783715416216,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03503649635036487,"floatShares":52267687,"shares":65854751,"eps":-0.669679,"marketStatus":"Market Closed","change":-0.24,"latestTime":"07-10 16:00:00 EDT","open":6.85,"high":6.87,"low":6.4,"amount":4188994.414576,"amplitude":0.068613,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.669679,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783929600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1518066000000,"exchange":"NASDAQ","adjPreClose":6.85,"preHourTrading":{"tag":"盘前","latestPrice":6.84,"preClose":6.85,"latestTime":"09:28 EDT","volume":79,"amount":542.0319244,"timestamp":1783690105069,"change":-0.01,"changeRate":-0.00146,"amplitude":0.085942},"postHourTrading":{"tag":"盘后","latestPrice":6.61,"preClose":6.61,"latestTime":"16:30 EDT","volume":5785,"amount":38239.545,"timestamp":1783715416216,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8030917827416504,"impliedVol":1.4619,"impliedVolPercentile":0.8446},"requestUrl":"/m/hq/s/EOLS/tweets","defaultTab":"tweets","newsList":[{"id":"2650711132","title":"Evolus Reports 115,000 RSU Inducement Grants to 38 New Hires Under 2023 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2650711132","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650711132?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:05","pubTimestamp":1783713950,"startTime":"0","endTime":"0","summary":"Evolus reports 115,000 RSU inducement grants to 38 new hires under 2023 planEvolus reported inducement equity awards totaling 115,000 restricted stock units granted from April–July 2026 to 38 newly hi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL583q0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650132784","title":"Evolus Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650132784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650132784?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:05","pubTimestamp":1783713900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nTUA51ZN6Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650913794","title":"Analysts’ Top Healthcare Picks: Evolus (EOLS), Annovis Bio (ANVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650913794","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650913794?lang=en_us&edition=fundamental","pubTime":"2026-07-09 03:20","pubTimestamp":1783538403,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Evolus (EOLS) and Annovis Bio (ANVS) with bullish se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-evolus-eols-annovis-bio-anvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-evolus-eols-annovis-bio-anvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4139","BK4588","LU0029874061.USD","LU0128526141.USD","BK4585","BK4137","XLV","ANVS","HCSG","EOLS","XBI","BK4581","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650997530","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650997530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650997530?lang=en_us&edition=fundamental","pubTime":"2026-07-08 23:50","pubTimestamp":1783525804,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-evolus-eols-alkermes-alks-and-volitionrx-vnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-evolus-eols-alkermes-alks-and-volitionrx-vnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XLV","MEDX","HCSG","LU0128526141.USD","LU0029874061.USD","BK4588","BK4585","EOLS","BK4137","XBI","PSCH","IBRN","VNRX","FBT","LABU","PSIL","BK4581","BK4198","BK4007","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649099950","title":"Evolus partners with IBSA to develop and market Profhilo in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2649099950","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649099950?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:10","pubTimestamp":1783516228,"startTime":"0","endTime":"0","summary":"Evolus (EOLS) has entered into an exclusive licensing and distribution agreement with IBSA, a Swiss multinational pharmaceutical company, to develo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evolus-partners-with-ibsa-to-develop-and-market-profhilo-in-the-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evolus-partners-with-ibsa-to-develop-and-market-profhilo-in-the-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649899640","title":"Evolus Partners with IBSA to License, Distribute Profhilo in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2649899640","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649899640?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:02","pubTimestamp":1783515733,"startTime":"0","endTime":"0","summary":"Evolus partners with IBSA to license, distribute Profhilo in USEvolus entered an exclusive licensing and distribution deal with Switzerland’s IBSA to develop and commercialize Profhilo in the US.Profh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL1nTBcn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649996768","title":"Evolus - Agreement not Expected to Impact 2026 or 2028 Financial Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996768?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:00","pubTimestamp":1783515601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUA1RXKFV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649996718","title":"Evolus - Under Terms, Co to Lead U.S. Regulatory Approval and Commercialization of Profhilo","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996718","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996718?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:00","pubTimestamp":1783515601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUA1RXKFV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649485996","title":"Evolus Announces Partnership with Ibsa to Develop and Commercialize Market-leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality","url":"https://stock-news.laohu8.com/highlight/detail?id=2649485996","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649485996?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:00","pubTimestamp":1783515601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUA1RXKFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648542281","title":"Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Evolus (EOLS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648542281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648542281?lang=en_us&edition=fundamental","pubTime":"2026-07-02 00:00","pubTimestamp":1782921623,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TransMedics Group (TMDX) and Evolus (EOLS) with bull...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-and-evolus-eols-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-and-evolus-eols-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065731478.USD","LABU","HCSG","BK4082","LU2324357040.USD","BK4585","XLV","XBI","EOLS","BK4588","BK4137","LU0128526141.USD","BK4581","TMDX","LU0029874061.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644710339","title":"Evolus Price Target Maintained With a $13.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2644710339","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644710339?lang=en_us&edition=fundamental","pubTime":"2026-06-17 18:14","pubTimestamp":1781691240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EOLS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 17, 2026 06:14 ET (10:14 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643581218","title":"Evolus shareholders elect Brady Stewart, Vikram Malik as Class II directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2643581218","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643581218?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:19","pubTimestamp":1781295579,"startTime":"0","endTime":"0","summary":"Evolus held its annual shareholder meeting on June 11, 2026.Shareholders elected Brady Stewart and Vikram Malik to the board.Shareholders backed an advisory vote on named executive officer compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evolus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL4BjkFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642341704","title":"Evolus (EOLS) Receives a Buy from Mizuho Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2642341704","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642341704?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:55","pubTimestamp":1780952116,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear reiterated a Buy rating on Evolus today and set a price target of $15.00. Ear covers the Healthcare sector, focusi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evolus-eols-receives-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evolus-eols-receives-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4207","BK4581","EOLS","XBI","XLV","BK4588","BK4007","MFG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641140242","title":"Evolus files $250M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2641140242","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641140242?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:50","pubTimestamp":1780692642,"startTime":"0","endTime":"0","summary":"16:47 EDT Evolus (EOLS) files $250M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evolus-files-250m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evolus-files-250m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641188140","title":"Evolus - May Offer up to $250 Mln of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641188140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641188140?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:46","pubTimestamp":1780692412,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D05G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636564488","title":"Evolus management joins Jefferies Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2636564488","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636564488?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:30","pubTimestamp":1779193821,"startTime":"0","endTime":"0","summary":"Evolus management to attend the Jefferies Global Healthcare Conference in New York City.Fireside chat scheduled for June 4, 2026 at 12:50 p.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL6GrCS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635895220","title":"3 High-Growth Insider-Owned Companies With Earnings Surging Up To 80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635895220","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635895220?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:05","pubTimestamp":1778843142,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has risen by 1.1%, contributing to an impressive 27% climb over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, companies that exhibit high growth potential and significant insider ownership can be particularly appealing, as they often indicate strong confidence from those closest to the business.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/7121000-choice1-main-header/1585186619635","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7121000-choice1-main-header/1585186619635"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-upst/upstart-holdings/news/3-high-growth-insider-owned-companies-with-earnings-surging","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-upst/upstart-holdings/news/3-high-growth-insider-owned-companies-with-earnings-surging","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4563","LABX","BK4116","BK4108","LU2089985449.USD","BK4539","LU0353189763.USD","LU1559883803.SGD","LU2063271972.USD","BK4505","IE00B19Z9Z06.USD","LU2360106780.USD","STUB","IE00B19Z9P08.USD","BK4007","UPST","UPSX","LU2360107168.USD","BK4588","BK4211","LU0353189680.USD","LU1852331112.SGD","BK4141","EOLS","BK4613","LU2087625088.SGD","LU0274383776.USD","LU2931357623.SGD","BK4608","IE00BZ9MQY76.HKD","LU1861215975.USD","LU2250418816.HKD","BK4532","LU1861220033.SGD","IE00B894F039.SGD","LU0566484027.USD","LU0056508442.USD","BK4214","BK4139","BK4187","BK4192","BK4561","LU2290526834.HKD","LU0097036916.USD","APPX","BK4023","BK4122","BK4129","BK4166","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634157280","title":"Evolus Plans to Launch Estyme Collection in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2634157280","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634157280?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:25","pubTimestamp":1778509512,"startTime":"0","endTime":"0","summary":"Evolus  said Monday that it will launch Estyme, its injectable hyaluronic acid gel collection, in Europe on May 16.The company said that the Estyme collection includes four injectable hyaluronic acid gels, including its Estyme Sculpt product, which has been developed to restore mid-face volume.Evolus said that the commercial launch in the region follows its successful CE Mark certification under the European Medical Device Regulation.Shares of the company were up 3% in early Monday trading.Price: 6.55, Change: +0.19, Percent Change: +2.91","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634289732","title":"Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2634289732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634289732?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:30","pubTimestamp":1778502600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA32H4VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633905782","title":"Evolus Faces Heightened Operational Risk from Overseas Manufacturing and Disaster Recovery Gaps","url":"https://stock-news.laohu8.com/highlight/detail?id=2633905782","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633905782?lang=en_us&edition=fundamental","pubTime":"2026-05-06 14:01","pubTimestamp":1778047266,"startTime":"0","endTime":"0","summary":"Evolus, Inc. (EOLS) has disclosed a new risk, in the Supply Chain category. Evolus, Inc. faces significant operational risk because it depends on t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evolus-faces-heightened-operational-risk-from-overseas-manufacturing-and-disaster-recovery-gaps?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evolus-faces-heightened-operational-risk-from-overseas-manufacturing-and-disaster-recovery-gaps?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evolus.com","stockEarnings":[{"period":"1week","weight":-0.042},{"period":"1month","weight":-0.0164},{"period":"3month","weight":0.548},{"period":"6month","weight":0.1699},{"period":"1year","weight":-0.3207},{"period":"ytd","weight":-0.006}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1111},{"period":"6month","weight":0.0877},{"period":"1year","weight":0.2063},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.240689},{"month":2,"riseRate":0.625,"avgChangeRate":0.185525},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.106703},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.036367},{"month":5,"riseRate":0.777778,"avgChangeRate":0.303421},{"month":6,"riseRate":0.666667,"avgChangeRate":0.016455},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.011803},{"month":8,"riseRate":0.375,"avgChangeRate":0.042226},{"month":9,"riseRate":0.25,"avgChangeRate":-0.131057},{"month":10,"riseRate":0.625,"avgChangeRate":-0.053423},{"month":11,"riseRate":0.5,"avgChangeRate":-0.016865},{"month":12,"riseRate":0.375,"avgChangeRate":-0.04679}],"exchange":"NASDAQ","name":"Evolus Inc.","nameEN":"Evolus Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evolus Inc.(EOLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evolus Inc.(EOLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evolus Inc.,EOLS,Evolus Inc.股票,Evolus Inc.股票老虎,Evolus Inc.股票老虎国际,Evolus Inc.行情,Evolus Inc.股票行情,Evolus Inc.股价,Evolus Inc.股市,Evolus Inc.股票价格,Evolus Inc.股票交易,Evolus Inc.股票购买,Evolus Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evolus Inc.(EOLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evolus Inc.(EOLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction